These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 30957594

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger.
    Kim JS, Oldenburg CE, Cooley G, Amza A, Kadri B, Nassirou B, Cotter SY, Stoller NE, West SK, Bailey RL, Keenan JD, Gaynor BD, Porco TC, Lietman TM, Martin DL.
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007127. PubMed ID: 30689671
    [Abstract] [Full Text] [Related]

  • 4. The effect of multiple rounds of mass drug administration on the association between ocular Chlamydia trachomatis infection and follicular trachoma in preschool-aged children.
    Lee JS, Muñoz BE, Mkocha H, Gaydos CA, Quinn TC, West SK.
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2761. PubMed ID: 24722392
    [Abstract] [Full Text] [Related]

  • 5. A Longitudinal Analysis of Chlamydial Infection and Trachomatous Inflammation Following Mass Azithromycin Distribution.
    Morberg DP, Alemayehu W, Melese M, Lakew T, Sisay A, Zhou Z, Cevallos V, Oldenburg CE, Porco TC, Lietman TM, Keenan JD.
    Ophthalmic Epidemiol; 2019 Feb; 26(1):19-26. PubMed ID: 30153085
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of Biannual Mass Azithromycin Distributions to Preschool-Aged Children on Trachoma Prevalence in Niger: A Cluster Randomized Clinical Trial.
    Arzika AM, Mindo-Panusis D, Abdou A, Kadri B, Nassirou B, Maliki R, Alsoudi AF, Zhang T, Cotter SY, Lebas E, O'Brien KS, Callahan EK, Bailey RL, West SK, Goodhew EB, Martin DL, Arnold BF, Porco TC, Lietman TM, Keenan JD, Macrolides Oraux pour Réduire les Décés Avec un Oeil sur la Resistance (MORDOR)–Niger Study Group.
    JAMA Netw Open; 2022 Aug 01; 5(8):e2228244. PubMed ID: 35997979
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trial.
    Amza A, Kadri B, Nassirou B, Stoller NE, Yu SN, Zhou Z, Chin S, West SK, Bailey RL, Mabey DC, Keenan JD, Porco TC, Lietman TM, Gaynor BD, PRET Partnership.
    PLoS Negl Trop Dis; 2012 Aug 01; 6(4):e1586. PubMed ID: 22545165
    [Abstract] [Full Text] [Related]

  • 10. Can we stop mass drug administration prior to 3 annual rounds in communities with low prevalence of trachoma?: PRET Ziada trial results.
    Yohannan J, Munoz B, Mkocha H, Gaydos CA, Bailey R, Lietman TA, Quinn T, West SK.
    JAMA Ophthalmol; 2013 Apr 01; 131(4):431-6. PubMed ID: 23392481
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma.
    Amza A, Kadri B, Nassirou B, Arzika AM, Austin A, Nyatigo F, Lebas E, Arnold BF, Lietman TM, Oldenburg CE.
    BMC Ophthalmol; 2021 Jan 06; 21(1):15. PubMed ID: 33407263
    [Abstract] [Full Text] [Related]

  • 13. Measuring Trachomatous Inflammation-Intense (TI) When Prevalence Is Low Provides Data on Infection With Chlamydia trachomatis.
    Zambrano AI, Muñoz BE, Mkocha H, Dize L, Gaydos CA, Quinn T, West SK.
    Invest Ophthalmol Vis Sci; 2017 Feb 01; 58(2):997-1000. PubMed ID: 28535271
    [Abstract] [Full Text] [Related]

  • 14. Targeted Mass Azithromycin Distribution for Trachoma: A Community-Randomized Trial (TANA II).
    Mahmud H, Haile BA, Tadesse Z, Gebresillasie S, Shiferaw A, Zerihun M, Liu Z, Callahan EK, Cotter SY, Varnado NE, Oldenburg CE, Porco TC, Lietman TM, Keenan JD.
    Clin Infect Dis; 2023 Aug 14; 77(3):388-395. PubMed ID: 37021692
    [Abstract] [Full Text] [Related]

  • 15. Mass drug administration of azithromycin for trachoma reduces the prevalence of genital Chlamydia trachomatis infection in the Solomon Islands.
    Marks M, Bottomley C, Tome H, Pitakaka R, Butcher R, Sokana O, Kako H, Solomon AW, Mabey DC.
    Sex Transm Infect; 2016 Jun 14; 92(4):261-5. PubMed ID: 26888658
    [Abstract] [Full Text] [Related]

  • 16. Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community.
    Ramadhani AM, Derrick T, Macleod D, Massae P, Malisa A, Mbuya K, Mtuy T, Makupa W, Roberts CH, Bailey RL, Mabey DCW, Holland MJ, Burton MJ.
    PLoS Negl Trop Dis; 2019 Jul 14; 13(7):e0007559. PubMed ID: 31306419
    [Abstract] [Full Text] [Related]

  • 17. Can corneal pannus with trachomatous inflammation--follicular be used in combination as an improved specific clinical sign for current ocular Chlamydia trachomatis infection?
    Derrick T, Holland MJ, Cassama E, Markham-David R, Nabicassa M, Marks M, Bailey RL, Last AR.
    Parasit Vectors; 2016 Jan 27; 9():30. PubMed ID: 26812948
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of a Single Dose of Azithromycin for Trachoma in Low-Prevalence Communities.
    Wilson N, Goodhew B, Mkocha H, Joseph K, Bandea C, Black C, Igietseme J, Munoz B, West SK, Lammie P, Kasubi M, Martin DL.
    Ophthalmic Epidemiol; 2019 Feb 27; 26(1):1-6. PubMed ID: 30543311
    [Abstract] [Full Text] [Related]

  • 19. Frequency of Mass Azithromycin Distribution for Ocular Chlamydia in a Trachoma Endemic Region of Ethiopia: A Cluster Randomized Trial.
    Lietman TM, Ayele B, Gebre T, Zerihun M, Tadesse Z, Emerson PM, Nash SD, Porco TC, Keenan JD, Oldenburg CE.
    Am J Ophthalmol; 2020 Jun 27; 214():143-150. PubMed ID: 32171768
    [Abstract] [Full Text] [Related]

  • 20. Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia.
    Harding-Esch EM, Sillah A, Edwards T, Burr SE, Hart JD, Joof H, Laye M, Makalo P, Manjang A, Molina S, Sarr-Sissoho I, Quinn TC, Lietman T, Holland MJ, Mabey D, West SK, Bailey R, Partnership for Rapid Elimination of Trachoma (PRET) study group.
    PLoS Negl Trop Dis; 2013 Jun 27; 7(6):e2115. PubMed ID: 23785525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.